1. Home
  2. KLIC vs ADMA Comparison

KLIC vs ADMA Comparison

Compare KLIC & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kulicke and Soffa Industries Inc.

KLIC

Kulicke and Soffa Industries Inc.

HOLD

Current Price

$79.75

Market Cap

3.3B

Sector

Technology

ML Signal

HOLD

Logo ADMA Biologics Inc

ADMA

ADMA Biologics Inc

HOLD

Current Price

$10.72

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KLIC
ADMA
Founded
1951
2004
Country
Singapore
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
2.4B
IPO Year
2004
2012

Fundamental Metrics

Financial Performance
Metric
KLIC
ADMA
Price
$79.75
$10.72
Analyst Decision
Strong Buy
Buy
Analyst Count
3
3
Target Price
$54.67
$28.00
AVG Volume (30 Days)
512.4K
9.6M
Earning Date
05-05-2026
05-06-2026
Dividend Yield
1.03%
N/A
EPS Growth
100.32
N/A
EPS
0.32
0.60
Revenue
$654,081,000.00
$42,219,783.00
Revenue This Year
$45.81
$27.46
Revenue Next Year
$11.35
$22.11
P/E Ratio
$249.69
$17.76
Revenue Growth
N/A
43.85
52 Week Low
$28.22
$7.21
52 Week High
$80.97
$25.67

Technical Indicators

Market Signals
Indicator
KLIC
ADMA
Relative Strength Index (RSI) 70.75 42.82
Support Level $61.26 $7.21
Resistance Level N/A $16.02
Average True Range (ATR) 2.94 0.52
MACD 1.47 0.33
Stochastic Oscillator 95.91 91.78

Price Performance

Historical Comparison
KLIC
ADMA

About KLIC Kulicke and Soffa Industries Inc.

Kulicke & Soffa Industries Inc. is a United States-based company that is principally engaged in designing, manufacturing, and selling capital equipment and expendable tools that are used for assembling semiconductor devices. The company has four reportable segments, which include Ball Bonding Equipment, Wedge Bonding Equipment, Advanced Solutions, and Aftermarket Products and Services. Its Ball Bonding Equipment segment which generates the majority of the revenue for the company includes results of the company from the design, development, manufacture and sale of ball bonding equipment and wafer level bonding equipment. The majority of its customers are located in the Asia-pacific region.

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.

Share on Social Networks: